In prostate cancer cells, Dkk3 expression inhibited cell proliferation and tumor growth, induced apoptosis, and sensitized cells to doxorubicin by c-JNK activation, mitochondrial redistribution of Bax, or by triggering Bcl-2 hypoexpression (4). Here, DKK3 is linked to prostate cancer.